TY - JOUR
T1 - Phosphodiesterase 4 inhibitors for psoriatic arthritis
AU - Zamora, Natalia V.
AU - Valerio-Morales, Ignacio Alfredo
AU - Lopez-Olivo, Maria Angeles
AU - Pan, Xin
AU - Suarez-Almazor, Maria E.
N1 - Publisher Copyright:
© 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2016/10/15
Y1 - 2016/10/15
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the benefits and harms of PDE4 inhibitors (e.g., apremilast) for the treatment of PsA.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the benefits and harms of PDE4 inhibitors (e.g., apremilast) for the treatment of PsA.
UR - http://www.scopus.com/inward/record.url?scp=84991384235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991384235&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD012401
DO - 10.1002/14651858.CD012401
M3 - Article
AN - SCOPUS:84991384235
SN - 1361-6137
VL - 2016
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 10
M1 - CD012401
ER -